Market Place
Sourcing Support
Canada approves Moderna`s RSV vaccine for adults aged 60 & older
09 Nov 2024 //
REUTERS
Moderna surprise profit on higher-than-expected COVID vaccine sales
08 Nov 2024 //
REUTERS
Carisma`s Moderna-powered cell therapy shrinks tumors in mice
07 Nov 2024 //
FIERCE BIOTECH
Moderna to Present at Upcoming Conferences in November 2024
31 Oct 2024 //
ACCESSWIRE
Merck, Moderna Launch Phase 3 Trial for NSCLC Treatment
28 Oct 2024 //
BUSINESSWIRE
Moderna mounts campaign to boost vaccine eligibility awareness
24 Oct 2024 //
FIERCE PHARMA
Moderna Named a Top Employer by Science for Tenth Consecutive Year
24 Oct 2024 //
ACCESSWIRE
UK’s first norovirus mRNA vaccine trial launched
24 Oct 2024 //
PHARMABIZ
Moderna to Report Q3 2024 Financial Results on Nov. 7, 2024
17 Oct 2024 //
ACCESSWIRE
GSK sues Moderna for US patent infringement over COVID, RSV vaccines
16 Oct 2024 //
REUTERS
Novavax Receives EU Authorization For Updated COVID Vaccine
09 Oct 2024 //
REUTERS
Alnylam drops patent lawsuit against Moderna over Covid-19 vaccine
07 Oct 2024 //
ENDPTS
Abbas Hussain Joins Moderna`s Board of Directors
02 Oct 2024 //
ACCESSWIRE
Moderna Doses First Participant In Ph 3 Norovirus Vaccine Trial
30 Sep 2024 //
ACCESSWIRE
Moderna, Cenra Healthcare joins To Promote mRNA Vaccines
30 Sep 2024 //
ACCESSWIRE
Moderna rebuked over second successive Spikevax marketing breach
30 Sep 2024 //
FIERCE PHARMA
Moderna blamed after kids sent $2,000 COVID vaccine trial offer
25 Sep 2024 //
FIERCE PHARMA
Pfizer v Moderna COVID vaccine patents battle to go to appeal in UK
25 Sep 2024 //
REUTERS
Moderna Gets Health Canada Approval For COVID-19 Vaccine Targeting KP.2 Variant
17 Sep 2024 //
ACCESSWIRE
Moderna Cuts R&D Spending, Focuses on Oncology
13 Sep 2024 //
CONTRACTPHARMA
Moderna forecasts lower sales next year, shares near four-year low
12 Sep 2024 //
REUTERS
Carisma And Moderna Expand In Vivo Cell Therapy To Autoimmune Diseases
11 Sep 2024 //
FIERCE BIOTECH
Carisma And Moderna Expand CAR-M Therapy Collaboration
10 Sep 2024 //
PR NEWSWIRE
Moderna`s Canadian Facility Gets Health Canada License
09 Sep 2024 //
ACCESSWIRE
Moderna`s Mpox Vaccine Shows Better Outcomes in Monkeys Than Bavarian Nordic
05 Sep 2024 //
FIERCE BIOTECH
Taiwan FDA Approves Moderna’s COVID-19 mRNA Vaccine For JN.1 Variant
02 Sep 2024 //
ACCESSWIRE
EU approves Moderna`s RSV vaccine for over 60s
24 Aug 2024 //
ECONOMICTIMES
Japan Approves Moderna`s COVID-19 mRNA Vaccine For SARS-COV-2 Variant JN.1
23 Aug 2024 //
ACCESSWIRE
Pfizer-BioNTech COVID-19 Vaccine Gets FDA Approval & Authorization
23 Aug 2024 //
BUSINESSWIRE
Moderna Therapeutics`s mResvia Receives Approval in Europe
22 Aug 2024 //
EMA
US FDA approves updated COVID shots ahead of fall and winter
22 Aug 2024 //
REUTERS
Omega Therapeutics Names Jennifer Nelson As Senior VP Of Research
14 Aug 2024 //
GLOBENEWSWIRE
Moderna unveils free Coursera curriculum on mRNA medicines to boost STEM skills
14 Aug 2024 //
FIERCE PHARMA
Moderna cuts 2024 sales forecast, sees low EU vaccine revenue into 2026
01 Aug 2024 //
REUTERS
Moderna Reports Q2 2024 Results And Provides Business Updates
01 Aug 2024 //
ACCESSWIRE
Leveragen And Moderna Collaborate On Antibody Technology
30 Jul 2024 //
BUSINESSWIRE
CDC Recommendations Reduce Long-Term US RSV Market Value: Airfinity
29 Jul 2024 //
FIERCE PHARMA
RSV vaccine makers vying for market share in second year of shots
29 Jul 2024 //
REUTERS
Should Merck Buy Out Moderna on Keytruda–Cancer Vaccine Partnership?
24 Jul 2024 //
BIOSPACE
Moderna co-founder Robert Langer to step down from vaccine maker`s board
24 Jul 2024 //
REUTERS
EU court criticises EU Commission`s handling of COVID-19 contracts
16 Jul 2024 //
REUTERS
Pfizer moves forward with once-daily weight-loss pill
12 Jul 2024 //
REUTERS
Moderna And Mitsubishi Tanabe Partner For mRNA Vaccines In Japan Market
08 Jul 2024 //
ACCESSWIRE
Moderna Receives BARDA Award For MRNA-Based Pandemic Influenza Vaccine
02 Jul 2024 //
ACCESSWIRE
Bird flu concern, US to award Moderna $176 million for vaccine development
02 Jul 2024 //
REUTERS
EMA Committee For Med Products For Positive Opinion MA Of Moderna’s Rsv Vaccine
28 Jun 2024 //
ACCESSWIRE
RSV vaccine makers’ shares fall as CDC adjusts shot guidance
28 Jun 2024 //
BIOPHARMADIVE
Carisma Announces Nomination of First In Vivo CAR-M Development Candidate
27 Jun 2024 //
PR NEWSWIRE
US CDC narrows age recommendation for RSV shots in US
27 Jun 2024 //
REUTERS
Moderna says its RSV shot is 50% effective across a second season
26 Jun 2024 //
REUTERS
GSK, Moderna, Novartis and more join Slope in new biospecimen consortium
25 Jun 2024 //
FIERCE BIOTECH
Moderna stock is lone omen of bird flu pandemic
17 Jun 2024 //
REUTERS
FDA asks COVID vaccine makers to target KP.2 strain, if feasible, for next shot
15 Jun 2024 //
REUTERS
Moderna Positive Phase 3 Data For Next-Gen COVID-19 Vaccine mRNA-1283
13 Jun 2024 //
ACCESSWIRE
Moderna COVID/flu combo vaccine superior to separate shots in trial
11 Jun 2024 //
REUTERS
Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine
07 Jun 2024 //
ACCESSWIRE
Moderna`s mRNA candidate picked for FDA`s Operation Warp Speed
06 Jun 2024 //
ENDPTS
Moderna and Myrtelle among those picked for FDA rare disease programme
06 Jun 2024 //
PHARMACEUTICAL TECHNOLOGY
FDA recommends updated Covid-19 vaccines targeting JN.1
06 Jun 2024 //
PHARMACEUTICAL TECHNOLOGY
Moderna`s mRNA-3705 Selected For FDA START Program For Methylmalonic Acidemia
06 Jun 2024 //
ACCESSWIRE
